Anson Funds Management’s Provention Bio PRVB Stock Holding History
Bought
Maintained
Sold
Other funds holding PRVB
Anson Funds Management's PRVB Position: Q3 2019 in Review
Anson Funds Management sold out of Provention Bio (PRVB) in Q3 2019, closing a stake of 159,337 shares — an estimated $1.93M sold.
Anson Funds Management first reported a position in PRVB in Q2 2019 and held it in 1 quarter. The position peaked at $1.93M in Q2 2019. 48 funds tracked by Wall St. Rank hold PRVB as of Q3 2019.
- Anson Funds Management reported no remaining Provention Bio position as of Q3 2019 after selling out during the quarter.
- Anson Funds Management sold 159,337 Provention Bio shares in Q3 2019, an estimated $1.93M.
- Anson Funds Management first reported a position in Provention Bio in Q2 2019 and held it in 1 quarter.
- Anson Funds Management's Provention Bio position peaked at $1.93M in Q2 2019.
- 48 funds tracked by Wall St. Rank held Provention Bio as of Q3 2019.
Based on Anson Funds Management's 13F filing for Q3 2019, filed 14 Nov 2019.